Dystrophy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

Dystrophy Stocks Recent News

Date Stock Title
Nov 19 BMY Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
Nov 18 BMY Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Nov 18 BMY Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
Nov 18 BMY EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
Nov 17 BMY Bristol-Myers Squibb: Buy This Bargain Before It's Gone
Nov 17 BMY Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock
Nov 15 BMY Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
Nov 15 TVTX Exploring Three High Growth Tech Stocks in the United States
Nov 15 SRPT Sarepta Therapeutics, Inc. (SRPT): Among 12 High Growth Large Cap Stocks to Buy Now
Nov 15 BMY Bristol Myers gets positive EMA opinion for repotrectinib
Nov 15 WVE Wave Life Sciences to Present at Jefferies London Healthcare Conference
Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer
Nov 15 WVE Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20
Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors
Nov 14 BMY Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
Nov 14 BNTC Benitec GAAP EPS of -$0.48
Nov 14 BMY Tudor Investment adds Infinera, Trane, exits Disney, UnitedHealth, among top Q3 trades
Nov 14 BNTC Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update
Nov 14 PTCT FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
Nov 14 SMMT Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
Dystrophy

Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

Browse All Tags